Glenmark Pharmaceuticals submits copy of press release
Date: 12-09-2016Glenmark Pharmaceuticals has submitted a copy of Press Release dated September 12, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Lidocaine Ointment USP, 5%’.
The above information is a part of company’s filings submitted to BSE.